Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Oberst

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Expert Review of Molecular Diagnostics|June 5, 2003
Possible role of matriptase in the diagnosis of ovarian cancerMichael D Johnson, Michael D Oberst, Chen-Yong Lin, et al.
The Journal of Biological Chemistry|May 10, 2003
The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitorMichael D Oberst, Cicely A Williams, Robert B Dickson, et al.
BMC Cancer|July 4, 2008
TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformationMichael D Oberst, Stacey J Beberman, Liu Zhao, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 23, 2003
Characterization of matriptase expression in normal human tissuesMichael D Oberst, Baljit Singh, Metin Ozdemirli, et al.
Mabs|December 9, 2014
CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomasMichael D Oberst, Stacy Fuhrmann, Kathy Mulgrew, et al.
American Journal of Physiology. Cell Physiology|April 13, 2004
Assembly of adherens junctions is required for sphingosine 1-phosphate-induced matriptase accumulation and activation at mammary epithelial cell-cell contactsRuei-Jiun Hung, Ia-Wen J Hsu, Jennifer L Dreiling, et al.
American Journal of Physiology. Cell Physiology|April 1, 2005
HAI-1 regulates activation and expression of matriptase, a membrane-bound serine proteaseMichael D Oberst, Li-Yuan L Chen, Ken-Ichi Kiyomiya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parametersMichael D Oberst, Michael D Johnson, Robert B Dickson, et al.
Plos One|May 11, 2012
The CEA/CD3-bispecific antibody MEDI-565 (MT111) binds a nonlinear epitope in the full-length but not a short splice variant of CEALi Peng, Michael D Oberst, Jiaqi Huang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2009
Potent control of tumor growth by CEA/CD3-bispecific single-chain antibody constructs that are not competitively inhibited by soluble CEARalf Lutterbuese, Tobias Raum, Roman Kischel, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Expert Review of Molecular Diagnostics|June 5, 2003
Possible role of matriptase in the diagnosis of ovarian cancerMichael D Johnson, Michael D Oberst, Chen-Yong Lin, et al.
The Journal of Biological Chemistry|May 10, 2003
The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitorMichael D Oberst, Cicely A Williams, Robert B Dickson, et al.
BMC Cancer|July 4, 2008
TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformationMichael D Oberst, Stacey J Beberman, Liu Zhao, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 23, 2003
Characterization of matriptase expression in normal human tissuesMichael D Oberst, Baljit Singh, Metin Ozdemirli, et al.
Mabs|December 9, 2014
CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomasMichael D Oberst, Stacy Fuhrmann, Kathy Mulgrew, et al.
American Journal of Physiology. Cell Physiology|April 13, 2004
Assembly of adherens junctions is required for sphingosine 1-phosphate-induced matriptase accumulation and activation at mammary epithelial cell-cell contactsRuei-Jiun Hung, Ia-Wen J Hsu, Jennifer L Dreiling, et al.
American Journal of Physiology. Cell Physiology|April 1, 2005
HAI-1 regulates activation and expression of matriptase, a membrane-bound serine proteaseMichael D Oberst, Li-Yuan L Chen, Ken-Ichi Kiyomiya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parametersMichael D Oberst, Michael D Johnson, Robert B Dickson, et al.
Plos One|May 11, 2012
The CEA/CD3-bispecific antibody MEDI-565 (MT111) binds a nonlinear epitope in the full-length but not a short splice variant of CEALi Peng, Michael D Oberst, Jiaqi Huang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2009
Potent control of tumor growth by CEA/CD3-bispecific single-chain antibody constructs that are not competitively inhibited by soluble CEARalf Lutterbuese, Tobias Raum, Roman Kischel, et al.
Pageof 2